| Literature DB >> 33043247 |
Ann Bremander1,2,3,4, Karina Malm4,5, Maria L Andersson1,4.
Abstract
BACKGROUND: A large number of patients with RA do not adhere to the recommended levels of physical activity to enhance health. According to EULAR recommendations, physical activity should be part of standard care in people with rheumatic diseases. There have been few larger studies on maintenance of physical activity over longer periods of time. The aim was to study self-reported physical activity levels over 7 years in patients with established rheumatoid arthritis (RA). In addition, to determine variables associated with maintenance or change of physical activity behavior.Entities:
Keywords: Exercise; Longitudinal study; Physical activity; Rheumatoid arthritis
Year: 2020 PMID: 33043247 PMCID: PMC7542713 DOI: 10.1186/s41927-020-00151-6
Source DB: PubMed Journal: BMC Rheumatol ISSN: 2520-1026
Descriptive of all patients who answered the questionnaire in 2010 and 2017
| All patients in 2010 | All patients in 2017 | ||
|---|---|---|---|
| N | 950 | 950 | |
| Age | 61 (13) | ||
| gender | Women, % | 72 | |
| Smoking habits | Non smoker, % | 42 | 42 |
| Smoker, % | 16 | 11 | |
| Previous smoker, | 42 | 47 | |
| RF, % | 66 | ||
| Disease duration, years | 8.7 (3.8) | ||
| BMI | 25.9 (4.2) | 25.9 (4.8) | |
| BMI | < 18.5, % | 1 | 1 |
| 18.5–24.9, % | 44 | 45 | |
| 25.0–29.9, % | 41 | 38 | |
| ≥30, % | 14 | 15 | |
| Fulfilling MVPA, % | 66 | 53 | |
| TJC | 5.4 (6.3) | 5.1 (6.4) | |
| SJC | 3.5 (5.1) | 2.9 (4.8) | |
| PatGA NRS (0–10) | 2.9 (2.3) | 3.0 (2.4) | |
| Pain NRS (0–10) | 3.3 (2.5) | 3.4 (2.5) | |
| Fatigue NRS (0–10) | 4.1 (2.8) | 4.1 (2.8) | |
| HAQ | 0.52 (0.55) | 0.60 (0.62) | |
| EQ 5D | 0.74 (0.20) | 0.72 (0.24) | |
| Tender regions | 4.3 (3.8) | 3.9 (3.7) | |
| Cardiovascular disease, % | 41 | 50 | |
| Pulmonary disease, % | 9 | 12 | |
| DMARD | No DMARD, % | 17 | 24 |
| cDMARDa | 54 | 43 | |
| bDMARDa | 26 | 27 | |
| Only corticosteroidsa | 3 | 6 |
awith and without corticosteroids
BMI Body mass index, TJC Tender joint count, SJC Swollen joint count, PatGA Patient Global Assessment, NRS Numeric rating scale, HAQ Health Assessment Questionnaire, EQ. 5D Euroqol 5 Dimensions, DMARDs Disease modifying anti-rheumatic drugs, cDMARDs Conventional DMARDs, CS Corticosteroids
Fig. 1Flowchart of meeting MVPA recommendations or not (non-MVPA) in 2010 and in 2017. MVPA, moderate physical activity and/or vigorous physical activity
Variables (from 2010) associated with meeting MVPA recommendations on both occasions (n = 389) vs. not meeting MVPA at any occasion (n = 211) (2010 and 2017). A logistic regression model adjusted for age, gender, and smoking habits
| 2010 | na | OR | 95% CI | ||
|---|---|---|---|---|---|
| Age | 594 | ||||
| Gender | men | 164 | 1 | ||
| women | 430 | 1.176 | 0.801–1.726 | 0.407 | |
| Smoking habits | Non smoker | 251 | 1 | ||
| Smoker | 92 | ||||
| Previous smoker | 251 | 0.743 | 0.507–1.089 | 0.128 | |
| Disease duration, years | 594 | 0.996 | 0.953–1.042 | 0.875 | |
| BMI | 18.5–24.9, % | 262 | 1 | ||
| < 18.5, % | 4 | 1.050 | 0.102–10.758 | 0.968 | |
| 25.0–29.9, % | 222 | ||||
| ≥30, % | 81 | ||||
| Cardiovasc | no | 361 | 1 | ||
| yes | 225 | ||||
| Pulmonary | no | 545 | 1 | ||
| yes | 44 | ||||
| TJC | 587 | ||||
| SJC | 587 | ||||
| PatGA (0–10) | 583 | ||||
| Pain (0–10) | 581 | ||||
| Fatigue (0–10) | 585 | ||||
| HAQ (0–3) | 589 | ||||
| EQ 5D (0–1) | 578 | ||||
| Tender regions (0–18) | 594 | ||||
| DMARD | No DMARD | 107 | 1 | ||
| cDMARDb | 309 | 0.886 | 0.549–1.432 | 0.622 | |
| Biologicb | 153 | 0.867 | 0.504–1.494 | 0.608 | |
| Only CS | 18 | 0.490 | 0.174–1.383 | 0.178 |
a included in the multivariate analyses, bwith and without corticosteroids
BMI Body mass index, TJC Tender joint count, SJC Swollen joint count, PatGA Patient Global Assessment, NRS Numeric rating scale, HAQ Health Assessment Questionnaire, EQ. 5D Euroqol 5 Dimensions, DMARDs Disease modifying anti-rheumatic drugs, cDMARDs Conventional DMARDs, CS Corticosteroids
Variables (from 2010) associated with a deterioration in in physical activity level between 2010 and 2017 (n = 234) vs. meeting MVPA recommendations at both occasions (n = 389). A logistic regression model adjusted for age, gender, and smoking habits
| 2010 | na | OR | 95% CI | ||
|---|---|---|---|---|---|
| Age | 616 | ||||
| Gender | men | 162 | 1 | ||
| women | 454 | 1.118 | 0.759–1.647 | 0.572 | |
| Smoking habits | Non smoker | 264 | 1 | ||
| Smoker | 93 | 1.572 | 0.956–2.587 | 0.075 | |
| Previous smoker | 259 | 1.263 | 0.873–1.826 | 0.216 | |
| Disease duration, years | 616 | 0.969 | 0.928–1.013 | 0.164 | |
| BMI | 18.5–24.9, % | 290 | 1 | ||
| < 18.5, % | 7 | 2.361 | 0.502–11.097 | 0.277 | |
| 25.0–29.9, % | 238 | ||||
| ≥30, % | 69 | ||||
| Cardiovasc | no | 375 | 1 | ||
| yes | 235 | ||||
| Pulmonary | no | 565 | 1 | ||
| yes | 47 | ||||
| TJC | 610 | 1.033 | 1.006–1.061 | 0.016 | |
| SJC | 606 | 1.025 | 0.992–1.059 | 0.138 | |
| PatGA (0–10) | 611 | 1.076 | 0.997–1.160 | 0.059 | |
| Pain (0–10) | 607 | ||||
| Fatigue (0–10) | 611 | ||||
| HAQ (0–3) | 611 | ||||
| EQ 5D (0–1) | 605 | ||||
| Tender regions (0–18) | 615 | ||||
| DMARD | No DMARD | 103 | 1 | ||
| cDMARDb | 335 | 1.572 | 0.960–2.574 | 0.072 | |
| Biologicb | 161 | 1.491 | 0.858–2.589 | 0.156 | |
| Only CS | 15 | 1.493 | 0.472–4.720 | 0.495 |
a included in the multivariate analyses, bwith and without corticosteroids
BMI Body mass index, TJC Tender joint count, SJC Swollen joint count, PatGA Patient Global Assessment, NRS Numeric rating scale, HAQ Health Assessment Questionnaire, EQ. 5D Euroqol 5 Dimensions, DMARDs Disease modifying anti-rheumatic drugs, cDMARDs Conventional DMARDs, CS Corticosteroids
Variables (from 2010) associated with an improvement in physical activity level between 2010 and 2017 (n = 211) vs. not meeting MVPA recommendations at any occasion (n = 116). A logistic regression model adjusted for age, gender, and smoking habits
| 2010 | na | OR | 95% CI | ||
|---|---|---|---|---|---|
| Age | 322 | ||||
| Gender | men | 97 | 1 | ||
| women | 225 | 1.061 | 0.628–1.972 | 0.826 | |
| Smoking habits | Non smoker | 125 | 1 | ||
| Smoker | 59 | 0.732 | 0.379–1.416 | 0.355 | |
| Previous smoker | 138 | 0.683 | 0.403–1.156 | 0.155 | |
| Disease duration, years | 322 | 0.991 | 0.931–1.054 | 0.764 | |
| BMI | 18.5–24.9, % | 105 | 1 | ||
| < 18.5, % | 3 | 1.964 | 0.166–23.159 | 0.592 | |
| 25.0–29.9, % | 130 | 0.829 | 0.427–1.458 | 0,516 | |
| ≥30, % | 62 | 0.555 | 0.276–1.116 | 0.099 | |
| Cardiovasc | no | 171 | 1 | ||
| yes | 144 | 0.623 | 0.371–1.048 | 0.074 | |
| Pulmonary | no | 283 | 1 | ||
| yes | 34 | 1.111 | 0.523–2.357 | 0.785 | |
| TJC | 318 | ||||
| SJC | 314 | 0.956 | 0.908–1.006 | 0.082 | |
| PatGA (0–10) | 311 | 0.904 | 0.812–1.006 | 0.065 | |
| Pain (0–10) | 315 | 0.915 | 0.826–1.015 | 0.094 | |
| Fatigue (0–10) | 317 | 0.929 | 0.852–1.012 | 0.092 | |
| HAQ (0–3) | 322 | 0.719 | 0.463–1.116 | 0.141 | |
| EQ 5D (0–1) | 310 | ||||
| Tender regions (0–18) | 322 | ||||
| DMARD | No DMARD | 50 | 1 | ||
| cDMARDb | 166 | 1.180 | 0.583–2.387 | 0.645 | |
| Biologicb | 85 | 1.401 | 0.650–3.021 | 0.390 | |
| Only CS | 13 | 1.263 | 0.326–4.897 | 0.735 |
a included in the multivariate analyses, bwith and without corticosteroids
BMI Body mass index, TJC Tender joint count, SJC Swollen joint count, PatGA Patient Global Assessment, NRS Numeric rating scale, HAQ Health Assessment Questionnaire, EQ. 5D Euroqol 5 Dimensions, DMARDs Disease modifying anti-rheumatic drugs, cDMARDs Conventional DMARDs, CS Corticosteroids